3D011-08 Monotherapy in Subjects With Advanced Solid Tumors
Status:
Not yet recruiting
Trial end date:
2023-12-31
Target enrollment:
Participant gender:
Summary
The purpose of this study is evaluate the the safety, tolerability, pharmacokinetics
profiles, and preliminary efficacy of 3D011-08 in subjects with advanced solid tumors.